HNP-3 activators comprise a class of chemicals that modulate the activity of Human Neutrophil Peptide-3 (HNP-3), which is a small peptide that belongs to the alpha-defensin family. These peptides are known for their role in the innate immune system as they contribute to the first line of defense against pathogens. HNP-3 itself is characterized by its ability to disrupt microbial membranes and is typically found in the granules of neutrophils, where it stands ready to be released upon cellular activation.
The activation of HNP-3 can occur through both direct and indirect means. Direct activators may interact with HNP-3 at a molecular level, potentially enhancing its affinity or binding capacity to microbial membranes. This could involve stabilizing the structure of the peptide in a conformation that is more effective for interaction with bacterial lipid bilayers, or by shielding the peptide from inhibitory interactions that could reduce its microbicidal activity. Indirect activators, on the other hand, may not interact with HNP-3 directly but instead, may influence the cellular mechanisms that regulate HNP-3 expression and release. For instance, certain chemicals might upregulate the transcription of the genes encoding HNP-3 or affect the post-translational processing and packaging of the peptide into neutrophil granules. Others might stimulate the degranulation process of neutrophils, resulting in the release of HNP-3 into the extracellular environment where it can exert its effects.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Lipopolysaccharide, E. coli O55:B5 | 93572-42-0 | sc-221855 sc-221855A sc-221855B sc-221855C | 10 mg 25 mg 100 mg 500 mg | $98.00 $171.00 $425.00 $1560.00 | 12 | |
LPS is a component of the outer membrane of Gram-negative bacteria. Interaction with LPS can trigger toll-like receptor 4 (TLR4) signaling, enhancing neutrophil activation and degranulation, leading to more HNP-3 release. | ||||||
Pam3Cys-Ser-(Lys)4, Hydrochloride | 112208-00-1 | sc-507471 | 2 mg | $550.00 | ||
Pam3CSK4 is a synthetic triacylated lipopeptide that acts as a TLR1/TLR2 agonist. Activation of these TLRs can stimulate neutrophil activation and degranulation, thus enhancing HNP-3 release. | ||||||
Polyinosinic acid - polycytidylic acid sodium salt, double-stranded | 42424-50-0 | sc-204854 sc-204854A | 10 mg 100 mg | $139.00 $663.00 | 2 | |
Poly(I:C) is a synthetic analog of double-stranded RNA and can activate TLR3. Neutrophil activation and degranulation can be triggered, leading to an increase in HNP-3 release. | ||||||
Imiquimod | 99011-02-6 | sc-200385 sc-200385A | 100 mg 500 mg | $67.00 $284.00 | 6 | |
Imiquimod is a TLR7 agonist. Activation of TLR7 can stimulate neutrophil activation and degranulation, thus enhancing HNP-3 release. | ||||||
R-848 | 144875-48-9 | sc-203231 sc-203231A sc-203231B sc-203231C | 5 mg 25 mg 100 mg 500 mg | $102.00 $306.00 $510.00 $1559.00 | 12 | |
R848 is a small molecule that can activate TLR7 and TLR8. This activation enhances neutrophil activation and degranulation, leading to an increase in HNP-3 release. | ||||||
Zymosan | 9010-72-4 | sc-296863 sc-296863A | 100 mg 1 g | $99.00 $599.00 | 1 | |
Zymosan is a glucan with repeating glucose units, which is recognized by TLR2. Zymosan interaction enhances neutrophil activation and degranulation, leading to increased HNP-3 release. | ||||||
LTB4 (Leukotriene B4) | 71160-24-2 | sc-201043 | 50 µg | $374.00 | 4 | |
LTB4 is a potent chemoattractant and activator of neutrophils, inducing degranulation and thus enhancing HNP-3 release. | ||||||
PAF C-16 | 74389-68-7 | sc-201009 sc-201009A | 5 mg 25 mg | $131.00 $300.00 | 10 | |
PAF is a potent phospholipid activator and mediator of many leukocyte functions, including neutrophil degranulation. This enhances HNP-3 release. | ||||||